Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06440694 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial)

Name: Colchicine to Quench the Inflammatory Response After Deep Vein Thrombosis (The Conquer-DVT Pilot Trial) — clinical trial record (NCT06440694)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorOttawa Hospital Research Institute

Started2025-07-07

View on ClinicalTrials.gov ↗

Amendment history

2026-07-22

Study Status, Contacts/Locations v3

Study sites3→4

2025-12-23

Study Status, Contacts/Locations v2

Study sites1→3

2025-07-09

Not Yet Recruiting→Recruiting Study Status, Study Description, Outcome Measures, Contacts/Locations v1

Trial statusNot Yet Recruiting→Recruiting

Start dateestimated 2024-06-03→confirmed 2025-07-07

Secondary endpoints17 entries, revised

Full-Scale Trial Secondary Outcome: Patient Reported V.VILLALTA Scale

Study sitesdetails revised at 1 of 1 site

2024-05-28

Original filing

Ottawa Hospital Research Institute

115 trials monitored

See 2 trials at risk

This trial seeks to assess the feasibility of a full-scale, double-blind, placebo-controlled, randomized trial assessing whether low-dose colchicine (0.5 mg daily) reduces the risk of post-thrombotic syndrome (PTS) in patients with proximal lower extremity deep vein thrombosis (DVT).

Trial Details

NCT Number	NCT06440694
Lead Sponsor	Ottawa Hospital Research Institute
Conditions	Venous Thromboembolism
Enrollment	150 participants
Start Date	2025-07-07
Primary Completion	2027-12-01 (estimated)
Study Completion	2027-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-23